| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
About This CME Activity
|
|
|
2010
|
|
4 |
p. 166-
1 p.
|
artikel
|
| 2 |
About this rare disorder
|
|
|
2004
|
|
4 |
p. 234-240
7 p.
|
artikel
|
| 3 |
A call for action: leadership is needed now on quality, safety, and pay for performance in community oncology
|
Bosserman, Linda D.
|
|
2005
|
|
4 |
p. 351-355
5 p.
|
artikel
|
| 4 |
A case of breast cancer detected by a pet dog
|
Welsh, James S.
|
|
2005
|
|
4 |
p. 324-
1 p.
|
artikel
|
| 5 |
A clustering of breast, lung, and fallopian tube cancers
|
Patel, Kevin J.
|
|
2009
|
|
4 |
p. 176-178
3 p.
|
artikel
|
| 6 |
Adjuvant therapy for colon cancer in the elderly: treat or don't treat?
|
Levitz, Jason S.
|
|
2005
|
|
4 |
p. 331-336
6 p.
|
artikel
|
| 7 |
Advances in the treatment of HER2+ breast cancer
|
|
|
2008
|
|
4 |
p. 192-196
5 p.
|
artikel
|
| 8 |
Aflibercept plus FOLFIRI improves survival in second-line treatment of metastatic colorectal cancer
|
Abraham, Jame
|
|
2012
|
|
4 |
p. 120-121
2 p.
|
artikel
|
| 9 |
Aflibercept trial is a milestone for patients with metastatic colorectal cancer
|
Kim, George P.
|
|
2012
|
|
4 |
p. 118-119
2 p.
|
artikel
|
| 10 |
A full plate
|
Bosserman, Linda D.
|
|
2009
|
|
4 |
p. 138-
1 p.
|
artikel
|
| 11 |
All that glitters is not gold: cancer-mimicking lesion in a cancer survivor
|
Kassem, Mohammed A.
|
|
2010
|
|
4 |
p. 175-177
3 p.
|
artikel
|
| 12 |
A new treatment option for refractory CLL arrives
|
Mehta, Dhaval
|
|
2010
|
|
4 |
p. 153-
1 p.
|
artikel
|
| 13 |
A patient's perspective
|
Johnson, Altheada L.
|
|
2004
|
|
4 |
p. 241-
1 p.
|
artikel
|
| 14 |
A patient with non-small cell lung cancer presenting with headaches and change in mental status
|
Mann, Justin
|
|
2012
|
|
4 |
p. 132-135
4 p.
|
artikel
|
| 15 |
Are Americans ready for cancer prevention in a pill?
|
Vanchieri, Cori
|
|
2005
|
|
4 |
p. 314-316
3 p.
|
artikel
|
| 16 |
Are anthracyclines still necessary in adjuvant therapy of early breast cancer?
|
Podrumar, Alida
|
|
2007
|
|
4 |
p. 209-
1 p.
|
artikel
|
| 17 |
Aromatase inhibitors in adjuvant therapy: promise and uncertainty
|
Ravdin, Peter M.
|
|
2004
|
|
4 |
p. 219-224
6 p.
|
artikel
|
| 18 |
Ask your lawyer
|
Doty, Lee W.
|
|
2005
|
|
4 |
p. 345-346
2 p.
|
artikel
|
| 19 |
Assessing the risk of breast cancer recurrence using the 21-gene assay
|
Smith, Frederick P.
|
|
2009
|
|
4 |
p. 151-152
2 p.
|
artikel
|
| 20 |
At last, healthcare reform: it's time to make it work
|
Bosserman, Linda D.
|
|
2010
|
|
4 |
p. 147-
1 p.
|
artikel
|
| 21 |
Bevacizumab in metastatic colorectal cancer and other settings
|
|
|
2004
|
|
4 |
p. 205-208
4 p.
|
artikel
|
| 22 |
Calcium phosphate mouth rinse for preventing oral mucositis
|
Abraham, Jame
|
|
2008
|
|
4 |
p. 171-172
2 p.
|
artikel
|
| 23 |
Caphosol reduces the severity of mucositis when started at the onset of cancer therapy
|
Papas, Athena
|
|
2008
|
|
4 |
p. 172-173
2 p.
|
artikel
|
| 24 |
Choosing your partner
|
Heifetz, Laurence J.
|
|
2004
|
|
4 |
p. 227-
1 p.
|
artikel
|
| 25 |
Chronic neutrophilic leukemia with JAK2 gene mutation
|
Ortiz-Cruz, Karen
|
|
2012
|
|
4 |
p. 127-131
5 p.
|
artikel
|
| 26 |
Clinical evaluation and treatment of insomnia in patients with cancer
|
Stepanski, Edward J.
|
|
2007
|
|
4 |
p. 245-250
6 p.
|
artikel
|
| 27 |
CMS off-label drug coverage initiative may die a slow death
|
Vanchieri, Cori
|
|
2006
|
|
4 |
p. 229-230
2 p.
|
artikel
|
| 28 |
Colon cancer: breaking new ground
|
Lichtman, Stuart M.
|
|
2004
|
|
4 |
p. 206-
1 p.
|
artikel
|
| 29 |
Community Cancer Care Preservation Act of 2007 introduced in House
|
Coplon, Steven M.
|
|
2007
|
|
4 |
p. 265-
1 p.
|
artikel
|
| 30 |
Conformal proton beam radiation therapy for prostate cancer: concepts and clinical results
|
Rossi Jr., Carl J.
|
|
2007
|
|
4 |
p. 235-240
6 p.
|
artikel
|
| 31 |
Cooporation trumps competition
|
Heifetz, Laurence J.
|
|
2004
|
|
4 |
p. 229-
1 p.
|
artikel
|
| 32 |
Cost-effective, high-quality care
|
Wong, Winston
|
|
2009
|
|
4 |
p. 155-156
2 p.
|
artikel
|
| 33 |
Crossing the digital Rubicon: incorporating the electronic medical record into your practice
|
|
|
2008
|
|
4 |
p. 179-180
2 p.
|
artikel
|
| 34 |
Data variables and distributions
|
Norman, Geoffrey R.
|
|
2009
|
|
4 |
p. 173-175
3 p.
|
artikel
|
| 35 |
Dealing with rising healthcare costs
|
|
|
2006
|
|
4 |
p. 225-226
2 p.
|
artikel
|
| 36 |
Decreasing the frequency of medical oncology admissions: progress toward a laudable goal
|
Mintzer, David M.
|
|
2010
|
|
4 |
p. 155-159
5 p.
|
artikel
|
| 37 |
Defining targets and protecting normal tissues in inverse-planned IMRT for prostate, head and neck, and gynecologic cancers: a comparative review
|
Dragun, Anthony E.
|
|
2005
|
|
4 |
p. 299-306
8 p.
|
artikel
|
| 38 |
Delivering the right care to the right patient at the right time
|
Schwartzberg, Lee S.
|
|
2011
|
|
4 |
p. 153-154
2 p.
|
artikel
|
| 39 |
Depression and quality of life in cancer patients undergoing chemotherapy: relation between the Zung Self-Rating Depression Scale and Functional Assessment of Cancer Therapy-General
|
Jang, Sekwon
|
|
2012
|
|
4 |
p. 122-126
5 p.
|
artikel
|
| 40 |
Differentiated thyroid cancer
|
Freeby, Matt
|
|
2007
|
|
4 |
p. 197-204
8 p.
|
artikel
|
| 41 |
Easing the tension between oncologists and hospice
|
Harsell, William
|
|
2004
|
|
4 |
p. 204-
1 p.
|
artikel
|
| 42 |
Editor's note
|
Bosserman, Linda D.
|
|
2004
|
|
4 |
p. 228-
1 p.
|
artikel
|
| 43 |
Evolving therapies for multiple myeloma
|
Raje, Noopur
|
|
2011
|
|
4 |
p. 181-182
2 p.
|
artikel
|
| 44 |
Evolving understanding and current management of patients with cancer of unknown primary site
|
Greco, F. Anthony
|
|
2010
|
|
4 |
p. 183-188
6 p.
|
artikel
|
| 45 |
Financial benchmarking: results from a survey of office-based oncology practices, part 2
|
Akscin, John
|
|
2007
|
|
4 |
p. 259-261
3 p.
|
artikel
|
| 46 |
First Annual Community Oncology Conference held in Washington, DC
|
|
|
2006
|
|
4 |
p. 181-
1 p.
|
artikel
|
| 47 |
Firstline treatment of patients with chronicphase chronic myelogenous leukemia: progress and remaining questions
|
Devetten, Marcel P.
|
|
2010
|
|
4 |
p. 160-165
6 p.
|
artikel
|
| 48 |
Fulfilling a duty to cancer patients
|
Vanchieri, Cori
|
|
2006
|
|
4 |
p. 185-186
2 p.
|
artikel
|
| 49 |
Fulvestrant offers an attractive treatment option for postmenopausal breast cancer
|
Scheff, Ronald J.
|
|
2007
|
|
4 |
p. 231-232
2 p.
|
artikel
|
| 50 |
Genomic classifiers have changed the way early-stage breast cancer is managed
|
Schultz, Michael J.
|
|
2009
|
|
4 |
p. 152-
1 p.
|
artikel
|
| 51 |
Government audits: ‘big brother’ is monitoring you
|
London, Susan
|
|
2011
|
|
4 |
p. 191-192
2 p.
|
artikel
|
| 52 |
Grappling with the consequences of the Medicare Modernization Act
|
|
|
2005
|
|
4 |
p. 366-
1 p.
|
artikel
|
| 53 |
Grassroots outreach making headway
|
Okon, Ted
|
|
2004
|
|
4 |
p. 246-250
5 p.
|
artikel
|
| 54 |
Guidelines for biosimilars open possibility for cheaper versions of approved biologics for cancer
|
Mechcatie, Elizabeth
|
|
2012
|
|
4 |
p. 138-140
3 p.
|
artikel
|
| 55 |
Healthcare reform: a mixed bag for oncology
|
Young, Patrick
|
|
2010
|
|
4 |
p. 192-
1 p.
|
artikel
|
| 56 |
Helping patients navigate the Part D labyrinth
|
Finkelstein, Joel B.
|
|
2007
|
|
4 |
p. 265-266
2 p.
|
artikel
|
| 57 |
Hospitalizations subsequent to the diagnosis of lung cancer: a clinical and financial analysis
|
Sadarangani, Tanesh R.
|
|
2006
|
|
4 |
p. 200-204
5 p.
|
artikel
|
| 58 |
Hypersensitivity reaction to carboplatin followed by reaction to cisplatin
|
Morris, Daniel J.
|
|
2005
|
|
4 |
p. 324-
1 p.
|
artikel
|
| 59 |
Images at your fingertips
|
Fried, John J.
|
|
2012
|
|
4 |
p. 141-142
2 p.
|
artikel
|
| 60 |
Improved NSCLC cure rates now certain
|
Greco, F. Anthony
|
|
2004
|
|
4 |
p. 209-
1 p.
|
artikel
|
| 61 |
Incorporating genetic testing and counseling in your practice
|
|
|
2008
|
|
4 |
p. 203-204
2 p.
|
artikel
|
| 62 |
Incorporating genomic classifiers in clinical pathways for early breast cancer
|
Abraham, Jame
|
|
2009
|
|
4 |
p. 148-150
3 p.
|
artikel
|
| 63 |
Investing in mid-level providers pays dividends
|
|
|
2007
|
|
4 |
p. 188-
1 p.
|
artikel
|
| 64 |
ITP in Patients With CLL: Practicing With Patrick F. Fogarty, MD
|
|
|
2010
|
|
4 |
p. 166-167
2 p.
|
artikel
|
| 65 |
Less toxicity, but just as good
|
Crabtree, Sandra J.
|
|
2007
|
|
4 |
p. 212-
1 p.
|
artikel
|
| 66 |
Let oncologists make the medical decisions
|
Okon, Ted
|
|
2008
|
|
4 |
p. 214-
1 p.
|
artikel
|
| 67 |
Lobbying members of Congress: a political action guide
|
|
|
2008
|
|
4 |
p. 175-176
2 p.
|
artikel
|
| 68 |
Long-term follow-up of a non-anthracycline regimen as adjuvant therapy for operable breast cancer
|
Abraham, Jame
|
|
2007
|
|
4 |
p. 207-208
2 p.
|
artikel
|
| 69 |
Malignant mesothelioma
|
Gadgeel, Shirish M.
|
|
2006
|
|
4 |
p. 215-224
10 p.
|
artikel
|
| 70 |
Management of hyperuricemia in adults with or at risk of tumor lysis syndrome
|
Seiter, Karen P.
|
|
2011
|
|
4 |
p. 163-170
8 p.
|
artikel
|
| 71 |
Managing the infusion room and improving patient satisfaction
|
Maxwell, Cathy
|
|
2011
|
|
4 |
p. 188-189
2 p.
|
artikel
|
| 72 |
Managing toxicities of EGFR inhibitors
|
|
|
2008
|
|
4 |
p. 202-203
2 p.
|
artikel
|
| 73 |
Many viewpoints, one view: improving outcomes
|
Bosserman, Linda D.
|
|
2007
|
|
4 |
p. 179-
1 p.
|
artikel
|
| 74 |
Medicare tries to get it right
|
Vastag, Brian
|
|
2004
|
|
4 |
p. 245-247
3 p.
|
artikel
|
| 75 |
MMA and the law of unintended consequences
|
|
|
2006
|
|
4 |
p. 227-
1 p.
|
artikel
|
| 76 |
Mucositis often overlooked and undertreated
|
Price, Angela
|
|
2008
|
|
4 |
p. 173-174
2 p.
|
artikel
|
| 77 |
New therapy prospects, a new app … and a new editor
|
Henry, David H.
|
|
2012
|
|
4 |
p. 113-
1 p.
|
artikel
|
| 78 |
Novel agents changing the outlook for renal cell carcinoma
|
|
|
2008
|
|
4 |
p. 206-209
4 p.
|
artikel
|
| 79 |
Occult systemic malignancy masquerading as thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
|
Francis, Kristin K.
|
|
2005
|
|
4 |
p. 339-343
5 p.
|
artikel
|
| 80 |
Ofatumumab for fludarabine- and alemtuzumab-refractory CLL
|
Abraham, Jame
|
|
2010
|
|
4 |
p. 151-152
2 p.
|
artikel
|
| 81 |
Oncology apps for your smart phone
|
Fried, John J.
|
|
2010
|
|
4 |
p. 182-
1 p.
|
artikel
|
| 82 |
Optimal integration of EGFR inhibitors in advanced colorectal cancer
|
Nelson, Douglas A.
|
|
2011
|
|
4 |
p. 155-162
8 p.
|
artikel
|
| 83 |
Ovarian cancer, silent no more
|
Gould, Randi Londer
|
|
2009
|
|
4 |
p. 142-144
3 p.
|
artikel
|
| 84 |
Panel weighs in on the changing face of oncology
|
London, Susan
|
|
2011
|
|
4 |
p. 189-190
2 p.
|
artikel
|
| 85 |
Paraneoplastic polymyositis associated with mesothelioma: a brief report
|
Schuster, Steven R.
|
|
2010
|
|
4 |
p. 178-180
3 p.
|
artikel
|
| 86 |
Payers and providers: a love match?
|
|
|
2008
|
|
4 |
p. 197-199
3 p.
|
artikel
|
| 87 |
Payers look to guidelines to gauge performance
|
|
|
2006
|
|
4 |
p. 225-226
2 p.
|
artikel
|
| 88 |
Performance reporting can pay off
|
|
|
2007
|
|
4 |
p. 187-188
2 p.
|
artikel
|
| 89 |
Platinum-based adjuvant therapy improves outcome in early NSCLC
|
|
|
2004
|
|
4 |
p. 208-210
3 p.
|
artikel
|
| 90 |
Pomalidomide in lenalidomide-refractory multiple myeloma and carfilzomib in refractory and newly diagnosed multiple myeloma
|
Abraham, Jame
|
|
2011
|
|
4 |
p. 179-181
3 p.
|
artikel
|
| 91 |
Preoperative evaluation of rectal cancer: I. Evaluation, diagnosis, and staging
|
Moore, Jill C.
|
|
2009
|
|
4 |
p. 161-165
5 p.
|
artikel
|
| 92 |
President Bush asked to extend the Medicare demonstration project
|
Okon, Ted
|
|
2005
|
|
4 |
p. 365-
1 p.
|
artikel
|
| 93 |
Preventing and managing VTE
|
|
|
2008
|
|
4 |
p. 182-183
2 p.
|
artikel
|
| 94 |
Proceedings from the Third Annual Community Oncology Conference
|
|
|
2008
|
|
4 |
p. 175-
1 p.
|
artikel
|
| 95 |
Professional management
|
Heifetz, Laurence J.
|
|
2004
|
|
4 |
p. 230-
1 p.
|
artikel
|
| 96 |
Profound and chronic iron deficiency anemia in a male Jehovah's Witness
|
Rossi, Suzanne L.
|
|
2009
|
|
4 |
p. 157-158
2 p.
|
artikel
|
| 97 |
Proving the quality of our care
|
Schwartzberg, Lee S.
|
|
2005
|
|
4 |
p. 289-
1 p.
|
artikel
|
| 98 |
PSA velocity: the view from 30,000 feet
|
Tucker, Steven J.
|
|
2006
|
|
4 |
p. 195-
1 p.
|
artikel
|
| 99 |
Pursuing quality care in 2008
|
|
|
2008
|
|
4 |
p. 188-190
3 p.
|
artikel
|
| 100 |
Quality measures for oncology coalescing
|
|
|
2004
|
|
4 |
p. 250-
1 p.
|
artikel
|
| 101 |
Recruiting and enrolling minority patients to cancer clinical trials
|
Park, Elyse R.
|
|
2007
|
|
4 |
p. 254-257
4 p.
|
artikel
|
| 102 |
Recruiting more elderly patients for clinical trials
|
Lichtman, Stuart M.
|
|
2006
|
|
4 |
p. 197-198
2 p.
|
artikel
|
| 103 |
Renal cell cancer, part II: traditional and emerging therapies
|
Tang, Mei
|
|
2009
|
|
4 |
p. 167-172
6 p.
|
artikel
|
| 104 |
Reporting on quality-of-life indicators —and getting paid for it
|
|
|
2004
|
|
4 |
p. 245-
1 p.
|
artikel
|
| 105 |
Sharpening your communication skills
|
Young, Patrick
|
|
2009
|
|
4 |
p. 180-182
3 p.
|
artikel
|
| 106 |
Spontaneous fatal recurrent tumor lysis syndrome in ductal breast carcinoma
|
Goyal, Hemant
|
|
2012
|
|
4 |
p. 136-137
2 p.
|
artikel
|
| 107 |
Talking to ODAC and meeting a stone wall
|
Henry, David H.
|
|
2008
|
|
4 |
p. 211-214
4 p.
|
artikel
|
| 108 |
The AC vs TC trial: a personal perspective
|
Jones, Stephen E.
|
|
2007
|
|
4 |
p. 209-210
2 p.
|
artikel
|
| 109 |
The $96 billion dilemma: who will pay for cancer care?
|
Helwick, Caroline
|
|
2009
|
|
4 |
p. 183-184
2 p.
|
artikel
|
| 110 |
The care of older cancer patients needs to be a priority for community oncologists
|
Lichtman, Stuart M.
|
|
2011
|
|
4 |
p. 184-185
2 p.
|
artikel
|
| 111 |
The 21-gene assay has many advantages —including precision
|
Smith Jr, William I.
|
|
2009
|
|
4 |
p. 154-155
2 p.
|
artikel
|
| 112 |
The impact of medical visits for chemotherapy-induced anemia and neutropenia on the patient and caregiver: a national survey
|
Fortner, Barry
|
|
2004
|
|
4 |
p. 211-217
7 p.
|
artikel
|
| 113 |
The new language of cancer care: contribution to working capital, human resource costs, practice efficiency, and opportunity costs
|
Fortner, Barry V.
|
|
2005
|
|
4 |
p. 357-362
6 p.
|
artikel
|
| 114 |
The smart medical oncology partnership
|
Heifetz, Laurence J.
|
|
2004
|
|
4 |
p. 226-230
5 p.
|
artikel
|
| 115 |
Tools for identifying, treating, monitoring, and preventing skin toxicities
|
London, Susan
|
|
2011
|
|
4 |
p. 186-187
2 p.
|
artikel
|
| 116 |
Top 10 PDA programs for oncology practices
|
Fried, John J.
|
|
2006
|
|
4 |
p. 206-
1 p.
|
artikel
|
| 117 |
Treatment of recurrent high-grade gliomas
|
Rosenfeld, Myrna R.
|
|
2011
|
|
4 |
p. 171-177
7 p.
|
artikel
|
| 118 |
Two for t: two groups and t-tests
|
Norman, Geoffrey R.
|
|
2010
|
|
4 |
p. 189-191
3 p.
|
artikel
|
| 119 |
Uncompensated costs associated with the outpatient management of cancer chemotherapy-associated febrile neutropenia
|
Calhoun, Elizabeth A.
|
|
2005
|
|
4 |
p. 293-296
4 p.
|
artikel
|
| 120 |
Undertreatment may contribute to deaths of older cancer patients
|
London, Susan
|
|
2011
|
|
4 |
p. 183-184
2 p.
|
artikel
|
| 121 |
Unmet expectations
|
Goldsmith, Myron
|
|
2005
|
|
4 |
p. 318-319
2 p.
|
artikel
|
| 122 |
Update on fulvestrant for hormone receptor-positive advanced breast cancer
|
Gradishar, William J.
|
|
2007
|
|
4 |
p. 220-228
9 p.
|
artikel
|
| 123 |
von Hippel-Lindau syndrome
|
Pithukpakorn, Manop
|
|
2004
|
|
4 |
p. 232-233
2 p.
|
artikel
|
| 124 |
Wanted: patients with mantle cell lymphoma
|
|
|
2004
|
|
4 |
p. 210-
1 p.
|
artikel
|
| 125 |
Weathering the Medicare storm
|
Schwartzberg, Lee S.
|
|
2004
|
|
4 |
p. 201-202
2 p.
|
artikel
|
| 126 |
What touches us all
|
Bosserman, Linda D.
|
|
2008
|
|
4 |
p. 165-
1 p.
|
artikel
|
| 127 |
What you need to know about anemia caused by chemotherapy and the medications called ESAs used to treat it
|
|
|
2008
|
|
4 |
p. 212-213
2 p.
|
artikel
|
| 128 |
When PSA levels rise following surgery or radiation therapy
|
Tucker, Steven J.
|
|
2006
|
|
4 |
p. 191-195
5 p.
|
artikel
|
| 129 |
Which treatment is the best?
|
House, Patti
|
|
2007
|
|
4 |
p. 211-
1 p.
|
artikel
|
| 130 |
Why isn't the 70-gene prognostic signature used more widely in this country?
|
Smerage, Jeffrey
|
|
2009
|
|
4 |
p. 153-154
2 p.
|
artikel
|
| 131 |
Wider access to clinical trials
|
Kirshner, Jeffrey J.
|
|
2004
|
|
4 |
p. 204-
1 p.
|
artikel
|
| 132 |
Your forum: practical, succinct, timely
|
Bosserman, Linda D.
|
|
2006
|
|
4 |
p. 175-
1 p.
|
artikel
|
Tijdschrift beschrijving